Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nuvation Bio Inc. (NUVB) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nuvation Bio Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1811063.
Total stock buying since 2020: $24,176,333.
Total stock sales since 2020: $66,418,361.
Total stock option exercises since 2020: $1,154,110.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 1,117,300 | $1,924,215 | 20,000 | $50,020 | 20,000 | $38,800 |
| 2024 | 1,050,084 | $3,037,568 | 0 | $0 | 659,947 | $1,115,310 |
| 2023 | 5,313,100 | $6,691,231 | 0 | $0 | 0 | $0 |
| 2022 | 250,000 | $483,930 | 2,500,000 | $14,000,000 | 0 | $0 |
| 2021 | 862,668 | $8,139,389 | 5,463,178 | $52,368,341 | 100,000 | $0 |
| 2020 | 390,000 | $3,900,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 617,300 | $1,103,915 | 0 | $0 | 0 | $0 |
| 2025-05 | 0 | $0 | 20,000 | $50,020 | 20,000 | $38,800 |
| 2025-04 | 500,000 | $820,300 | 0 | $0 | 0 | $0 |
| 2024-10 | 100,000 | $219,800 | 0 | $0 | 0 | $0 |
| 2024-06 | 950,084 | $2,817,768 | 0 | $0 | 0 | $0 |
| 2024-05 | 0 | $0 | 0 | $0 | 659,947 | $1,115,310 |
| 2023-02 | 5,313,100 | $6,691,231 | 0 | $0 | 0 | $0 |
| 2022-12 | 174,959 | $344,804 | 0 | $0 | 0 | $0 |
| 2022-11 | 75,041 | $139,126 | 0 | $0 | 0 | $0 |
| 2022-04 | 0 | $0 | 2,500,000 | $14,000,000 | 0 | $0 |
| 2021-12 | 0 | $0 | 1,900,000 | $18,755,000 | 0 | $0 |
| 2021-11 | 185,026 | $1,422,109 | 2,295,036 | $21,379,551 | 0 | $0 |
| 2021-10 | 0 | $0 | 1,060,000 | $10,161,150 | 0 | $0 |
| 2021-07 | 56,598 | $489,006 | 56,598 | $489,006 | 0 | $0 |
| 2021-04 | 464,500 | $4,594,740 | 0 | $0 | 0 | $0 |
| 2021-03 | 156,544 | $1,633,534 | 151,544 | $1,583,634 | 0 | $0 |
| 2021-02 | 0 | $0 | 0 | $0 | 100,000 | $0 |
| 2020-07 | 390,000 | $3,900,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-18 | Markel Stacy (CHIEF PEOPLE OFFICER) | Buy | 10,000 | 1.71 | 17,100 |
| 2025-06-17 | Sauvage Philippe (Chief Financial Officer) | Buy | 4,000 | 1.79 | 7,160 |
| 2025-06-16 | Sauvage Philippe (Chief Financial Officer) | Buy | 3,300 | 1.83 | 6,055 |
| 2025-06-16 | Sjogren Colleen (Chief Commercial Officer) | Buy | 50,000 | 1.81 | 90,350 |
| 2025-06-16 | Wentworth Kerry (CHIEF REGULATORY OFFICER) | Buy | 50,000 | 1.79 | 89,750 |
| 2025-06-16 | Hung David (PRESIDENT AND CEO) | Buy | 500,000 | 1.79 | 893,500 |
| 2025-05-02 | Liu Dongfang (CHIEF MEDICAL OFFICER) | Sale | 20,000 | 2.50 | 50,020 |
| 2025-05-02 | Liu Dongfang (CHIEF MEDICAL OFFICER) | Option Ex | 20,000 | 1.94 | 38,800 |
| 2025-04-07 | Hung David (PRESIDENT AND CEO) | Buy | 300,000 | 1.62 | 487,500 |
| 2025-04-04 | Hung David (PRESIDENT AND CEO) | Buy | 200,000 | 1.66 | 332,800 |
| 2024-10-08 | Mashal Robert | Buy | 100,000 | 2.20 | 219,800 |
| 2024-06-25 | Cui Xiangmin | Buy | 277,895 | 2.97 | 825,348 |
| 2024-06-24 | Cui Xiangmin | Buy | 336,874 | 2.98 | 1,003,884 |
| 2024-06-21 | Cui Xiangmin | Buy | 75,411 | 3.00 | 226,233 |
| 2024-06-20 | Cui Xiangmin | Buy | 87,715 | 2.99 | 262,267 |
| 2024-06-11 | Blickenstaff Kim D | Buy | 172,189 | 2.90 | 500,036 |
| 2024-05-24 | Welch Daniel G | Option Ex | 659,947 | 1.69 | 1,115,310 |
| 2023-02-21 | Biotech Opportunity Gp, Llc | Buy | 53,000 | 1.36 | 72,133 |
| 2023-02-20 | Biotech Opportunity Gp, Llc | Buy | 117,100 | 1.36 | 159,490 |
| 2023-02-19 | Biotech Opportunity Gp, Llc | Buy | 5,143,000 | 1.26 | 6,459,608 |
| 2022-12-05 | Falberg Kathryn E (Director) | Buy | 43,000 | 1.95 | 83,979 |
| 2022-12-02 | Falberg Kathryn E (Director) | Buy | 47,000 | 1.98 | 93,201 |
| 2022-12-01 | Falberg Kathryn E (Director) | Buy | 84,959 | 1.97 | 167,624 |
| 2022-11-30 | Falberg Kathryn E (Director) | Buy | 75,041 | 1.85 | 139,126 |
| 2022-04-05 | Omega Fund V Gp Manager, Ltd. (10% Owner) | Sale | 2,500,000 | 5.60 | 14,000,000 |
| 2021-12-15 | Omega Fund V Gp Manager, Ltd. (10% Owner) | Sale | 500,000 | 10.07 | 5,035,000 |
| 2021-12-07 | Omega Fund V Gp Manager, Ltd. (10% Owner) | Sale | 1,400,000 | 9.80 | 13,720,000 |
| 2021-11-24 | Biotech Opportunity Gp, Llc | Buy | 185,026 | 7.69 | 1,422,109 |
| 2021-11-23 | Omega Fund V Gp Manager, Ltd. (10% Owner) | Sale | 36 | 9.75 | 351 |
| 2021-11-22 | Omega Fund V Gp Manager, Ltd. (10% Owner) | Sale | 295,000 | 9.76 | 2,879,200 |
| 2021-11-03 | Omega Fund V Gp Manager, Ltd. (10% Owner) | Sale | 2,000,000 | 9.25 | 18,500,000 |
| 2021-10-29 | Omega Fund V Gp Manager, Ltd. (10% Owner) | Sale | 45,000 | 9.27 | 417,150 |
| 2021-10-28 | Omega Fund V Gp Manager, Ltd. (10% Owner) | Sale | 1,015,000 | 9.60 | 9,744,000 |
| 2021-07-31 | Biotech Opportunity Gp, Llc | Buy | 56,598 | 8.64 | 489,006 |
| 2021-07-31 | Biotech Opportunity Gp, Llc | Sale | 56,598 | 8.64 | 489,006 |
| 2021-04-13 | Biotech Opportunity Gp, Llc | Buy | 31,500 | 10.27 | 323,536 |
| 2021-04-12 | Biotech Opportunity Gp, Llc | Buy | 133,000 | 9.49 | 1,261,904 |
| 2021-04-09 | Biotech Opportunity Gp, Llc | Buy | 300,000 | 10.03 | 3,009,300 |
| 2021-03-31 | Biotech Opportunity Gp, Llc | Buy | 151,544 | 10.45 | 1,583,634 |
| 2021-03-31 | Biotech Opportunity Gp, Llc | Sale | 151,544 | 10.45 | 1,583,634 |
| 2021-03-30 | Bazemore Robert B (Director) | Buy | 5,000 | 9.98 | 49,900 |
| 2021-02-10 | Cooper Graham K | Option Ex | 25,000 | .00 | 0 |
| 2021-02-10 | Sharp Shalini | Option Ex | 25,000 | .00 | 0 |
| 2021-02-10 | Hasnain Faheem | Option Ex | 25,000 | .00 | 0 |
| 2021-02-10 | Bradbury Daniel | Option Ex | 25,000 | .00 | 0 |
| 2020-07-06 | Biotech Opportunity Gp, Llc | Buy | 390,000 | 10.00 | 3,900,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NUVB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nuvation Bio Inc. (symbol NUVB, CIK number 1811063) see the Securities and Exchange Commission (SEC) website.